Skip to main content

Experimental Evaluation of an Altered Tryptophan Metabolism in Fibromyalgia

  • Chapter
Developments in Tryptophan and Serotonin Metabolism

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 527))

Abstract

Fibromyalgia (FM) is a prevalent syndrome with chronic pain and a hypothesised underlying disturbance of the tryptophan (TRP) metabolism. We performed a tryptophan depletion (TD) test in 17 FM patients and 17 controls. TRP, 5-hydroxyindoleacetic acid (5-HIAA), kynurenine (KYN), and Interleukin-6 (IL-6) were measured. Additionally pain perception was monitored in the FM patients. FM patients and controls exhibited a decrease of TRP and KYN during TD. 5-HIAA levels also decreased in all controls and in 11 FM patients, but showed a marked increase in 6 FM patients. IL-6 significantly increased during TD in the patients, but not in the controls. Pain perception was not affected in the FM patients. These data demonstrate an altered TRP metabolism in a subgroup of FM patients, where the TD seems to activate 5-HT metabolism and IL-6 production. Our findings may have diagnostic as well as therapeutic implications in the field of fibromyalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, P. Tugwell, S.M. Campbell, M. Abeles, P. Clark, A.G. Fam, S..I. Farber, J.J. Fiechtner, C.M. Franklin, R.A. Garter. D. Hamaty, J. Lessrad, A.S. Lichtbroun, A.T. Masi, G.A. McCain, W.J.Reynolds, T.J. Romano, I.J.Russell, and R.P. Sheon, The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee [see comments]Arthritis.Rheum 33160­-172 (1990)

    Google Scholar 

  2. F. Wolfe, K. Ross, J. Anderson, and I.J. Russell, Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptomsJ. Rheumatol.22, 151–156 (1995).

    PubMed  CAS  Google Scholar 

  3. F. Wolfe, K. Ross, J. Anderson, I.J. Russell, and L. Hebert, The prevalence and characteristics of fibromyalgia in the general populationArthritis. Rheum. 3819–28 (1995).

    Article  PubMed  CAS  Google Scholar 

  4. R.S. Katz and H.M. Kravitz, Fibromyalgia, depression, and alcoholism: a family history studyJ. Rheumatol. 23149–154 (1996).

    PubMed  CAS  Google Scholar 

  5. J.I. Hudson, D.L. Goldenberg, H.G. Pope, P.E. Keck, and L. Schlesinger, Comorbidity of fibromyalgia with medical and psychiatric disordersAm.J.Med. 92363–367 (1992).

    Article  PubMed  CAS  Google Scholar 

  6. M. Offenbächer, K. Glatzeder, and M. Ackenheil, Self reported depression, familial history of depression and fibromyalgia (FM) and psychological distress in patients with FMZ.Rheumatol. 5794–96 (1998).

    Article  Google Scholar 

  7. J.I. Hudson and H.G. Pope. The relationship between fibromyalgia and major depressive disorderRheum. Dis. Clin. North Am. 22285–303 (1996).

    Article  PubMed  CAS  Google Scholar 

  8. L.M. Arnold, P.E. Keck, and J.A. Welge, Antidepressant treatment of fibromyalgia. A meta-analysis and reviewPsychosomatics 41104–113 (2000).

    Article  PubMed  CAS  Google Scholar 

  9. D. Fishbain, Evidence-based data on pain relief with antidepressantsAnn. Med. 32305–316 (2000).

    Article  PubMed  CAS  Google Scholar 

  10. H. Moldofsky, Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin, and painAdv. Neurol. 3351–57 (1982).

    PubMed  CAS  Google Scholar 

  11. F. WolfeI.J.Russell, G. Vipraio, K. Ross, and J. Anderson, Serotonin levels, pain threshold, and fibromyalgia symptoms in the general populationJ. Rheumatol. 24555–559 (1997).

    PubMed  CAS  Google Scholar 

  12. T. Stratz, W. Samborski, P. Hrycaj, T. Pap, S. Mackiewicz, P. Mennet, and W. Muller, Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritisMed. Klin. 88458–462 (1993).

    CAS  Google Scholar 

  13. I.J. Russell, H. Vaeroy, M. Javors, and F. Nyberg, Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis [see comments]Arthritis.Rheum. 35550–556 (1992).

    Article  PubMed  CAS  Google Scholar 

  14. I.1. Russell, Neurochemical Pathogenesis of Fibromyalgia SyndromeJ. Musculoscheletal Pain4, 61–92 (1996).

    Article  Google Scholar 

  15. I.J. Russell, J.E. Michalek, G.A. Vipraio, E.M. Fletcher, M.A. Javors, and C.A. Bowden, Platelet 3H­imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome [see comments]J. Rheumatol. 19104–109 (1992).

    PubMed  CAS  Google Scholar 

  16. M.J. Schwarz, Spaeth M., Müller-Bardorff H., Pongratz D., Bondy B., and M. Ackenheil Relationship of Substance P, 5-Hydroxyindoleacetic Acid and Tryptophan in Serum of Fibromyalgia PatientsNeurosci. Lett. 259196–198 (1999).

    Article  PubMed  CAS  Google Scholar 

  17. G. Neeck and W. Riedel, Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress?Baillieres Clin. Rheumatol. 8763–775 (1994).

    Article  PubMed  CAS  Google Scholar 

  18. A. Heils, A. Teufel, S. Petri, G. Stober, P. Riederer, D. Bengel, and K.P. Lesch, Allelic variation of human serotonin transporter gene expressionJ. Neuroche m. 662621–2624 (1996).

    Article  CAS  Google Scholar 

  19. P.K. Eide and K. Hole, Interactions between serotonin and substance P in the spinal regulation of nociceptionBrain Res.550, 225–230 (1991).

    Article  PubMed  CAS  Google Scholar 

  20. W.M. Pardridge, Blood-brain barrier carrier-mediated transport and brain metabolism of amino acidsNeurochem. Res.23, 635–644 (1998).

    Article  PubMed  CAS  Google Scholar 

  21. A. Frazer and J.G. Hensler, Serotonin, in:Basic Neurochemistryedited by G. J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher, & M. D. Uhler, 6 edition (Lippincott-Raven Publishers, Philadelphia, 1999), pp. 263–292.

    Google Scholar 

  22. M.W. Taylor and G.S. Feng, Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolismFASEB J. 52516–2522 (1991).

    PubMed  CAS  Google Scholar 

  23. R.R. Brown, Y. Ozaki, S.P. Datta, E.C. Borden, P.M. Sondel, and D.G. Malone, Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDSAdv. Exp. Med. Biol. 294425­-435 (1991).

    Article  PubMed  CAS  Google Scholar 

  24. R. Stancampiano, F. Melis, L. Sarais, S. Cocco, C. Cugusi, and F. Fadda, Acute administration of a tryptophan-free amino acid mixture decreases 5–1-IT release in rat hippocampus in vivoAm. J. Physiol272, R991–R994 (1997).

    PubMed  CAS  Google Scholar 

  25. G. Biggio, F. Fadda, P. Fanni, A. Tagliamonte, and G.L. Gessa, Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free dietLife Sci.14, 1321–1329 (1974).

    Article  PubMed  CAS  Google Scholar 

  26. G.L. Gessa, G. Biggio, F. Fadda, G.U. Corsini, and A. Tagliamonte, Tryptophan-free diet: a new means for rapidly decreasing brain tryptophan content and serotonin synthesisActa Vitaminol. Enzymol. 2972–78 (1975).

    PubMed  CAS  Google Scholar 

  27. S.N. Young, S.E. Smith, R.O. Pihl, and F.R. Ervin, Tryptophan depletion causes a rapid lowering of mood in normal malesPsychopharmacology (Berl) 87173–177 (1985).

    Article  CAS  Google Scholar 

  28. C. Benkelfat, M.A. Ellenbogen, P. Dean, R.M. Palmour, and S.N. Young, Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disordersArch. Gen. Psychiatry 51687–697 (1994).

    Article  PubMed  CAS  Google Scholar 

  29. W.A. Williams, S.E. Shoaf, D. Hommer, R. Rawlings, and M. Linnoila, Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteersJ. Neurochem.72, 1641–1647 (1999).

    Article  PubMed  CAS  Google Scholar 

  30. M.P. Heyes, C.Y. Chen, E.O. Major, and K. Saito, Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.Biochem.J. 326351–356 (1997).

    PubMed  CAS  Google Scholar 

  31. C. Huber, J.R. Batchelor, D. Fuchs, A. Hausen, A. Lang, D. Niederwieser, G. Reibnegger, P. Swetly, J. Troppmair, and H. Wachter, Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gammaJ. Exp. Med. 160310–316 (1984).

    Article  PubMed  CAS  Google Scholar 

  32. A.A. Beharka, M. Meydani, D. Wu, L.S. Leka, A. Meydani, and S.N. Meydani, lnterleukin-6 production does not increase with ageJ. Geroniol. A Biol. Sci. Med. Sci. 56B81–B88 (2001).

    Article  CAS  Google Scholar 

  33. P.L. Delgado, D.S. Chamey, L.H. Price, G.K. Aghajanian, H. Landis, and G.R. Heninger, Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophanArch.Gen.Psychiatry 47411–418 (1990).

    Article  PubMed  CAS  Google Scholar 

  34. C. Bell, J. Abrams, and D. Nutt, Tryptophan depletion and its implications for psychiatryBr. J. Psychiatry . 178399–405 (2001).

    Article  PubMed  CAS  Google Scholar 

  35. D.L. Murphy, I.C. Campbell, and J.L. Costa, The brain serotonergic system in the affective disordersProg. Neuropsychopharmacol. 25–31 (1978).

    Article  PubMed  CAS  Google Scholar 

  36. H.Y. Meltzer, Role of serotonin in depressionAnn. N. Y. Acad. Sci.600, 486–499 (1990).

    Article  PubMed  CAS  Google Scholar 

  37. J.D. Bremner, R.B. Innis, R.M. Salomon, L.H. Staib, C.K. Ng, H.L. Miller, R.A. Bronen, J.H. Krystal, J. Duncan, D. Rich, L.H. Price, R. Malison, H. Dey, R. Soufer, and D.S. Chamey, Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapseArch. Gen. Psychiatry 54364–374 (1997).

    Article  PubMed  CAS  Google Scholar 

  38. A. Neumeister, N. Praschak-Rieder, B. Besselmann, M.L. Rao, J. Gluck, and S. Kasper, Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapyArch. Gen. Psychiatry 54133–138 (1997).

    Article  PubMed  CAS  Google Scholar 

  39. L.L. Carpenter, G.M. Anderson, G.H. Pelton, J.A. Gudin, P.D. Kirwin, L.H. Price, G.R. Heninger, and C.J. McDougle, Tryptophan depletion during continuous CSF sampling in healthy human subjects.Neuropsychopharmacology 1926–35 (1998).

    Article  PubMed  CAS  Google Scholar 

  40. A.V. Ravindran, J. Griffiths, Z. Merali, V.J. Knott, and H. Anisman, Influence of acute tryptophan depletion on mood and immune measures in healthy malesPsychoneuroendocrinology 2499–1I3 (1999).

    Article  PubMed  CAS  Google Scholar 

  41. M. Maes, R. Verkerk, L. Delmeire, A. Van Gastel, F. van Hunsel, and S. Scharpe, Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgiaPsychiatry Res. 9711–20 (2000).

    Article  PubMed  CAS  Google Scholar 

  42. F.V. Abbott, P. Etienne, K.B. Franklin, M.J. Morgan, M.J. Sewitch, and S.N. Young, Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humansPsychopharmacology (Berl) 10860–66 (1992).

    Article  CAS  Google Scholar 

  43. F.A. Moreno, C. McGavin, T.P. Malan, 00C1.J. Gelenberg, G.R. Heninger, A.A. Mathe, and P.L. Delgado, Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: results from single lumbar puncture sampling techniqueInt. J. Neuropsychopharmacol. 3277–283 (2000).

    Article  PubMed  CAS  Google Scholar 

  44. S. Bonaccorso, A.H. Lin, R. Verkerk, F. van Hunsel, I. Libbrecht, S. Scharpe, L. DeClerck, M. Biondi, A. Janca, and M. Maes, Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteersJ. Affect. Disord. 4875–82 (1998).

    Article  PubMed  CAS  Google Scholar 

  45. B. Widner, F. Leblhuber, J. Walli, G.P. Tilz, U. Demel, and D. Fuchs, Degradation of tryptophan in neurodegenerative disordersAdv. Exp. Med. Biol. 467133–138 (1999).

    Article  PubMed  CAS  Google Scholar 

  46. M. Maes, S. Scharpe, H.Y. Meltzer, G. Okayli, E. Bosmans, P. D’Hondt, B.V. Vanden Bossche, and P. Cosyns, Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune responsePsychiatry Res. 54143–160 (1994).

    Article  PubMed  CAS  Google Scholar 

  47. J. Wang and A.J. Dunn, The role of interleukin-6 in the activation of the hypothalamo-pituitary­adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 betaBrain Res. 815337–348 (1999).

    Article  PubMed  CAS  Google Scholar 

  48. J. Wang and A.J. Dunn, Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolismNeurochem. Int. 33143–154 (1998).

    Article  PubMed  CAS  Google Scholar 

  49. S. Zalcman, J.M. Green-Johnson, L. Murray, D.M. Nance, D. Dyck, H. Anisman, andA.H.Greenberg, Cytokine-specific central monoamine alterations induced by interleukin-I, -2 and —6Brain Res. 64340­-49 (1994).

    Article  PubMed  CAS  Google Scholar 

  50. N. Barkhudaryan and A.J. Dunn, Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axisNeurochem. Res. 24.1169–1180 (1999).

    Article  PubMed  CAS  Google Scholar 

  51. W. Allaerts, P.H. Jeucken, R. Debets, S. Hoefakker, E. Claassen, and H.A. Drexhage, Heterogeneity of pituitary folliculo-stellate cells: implications for interleukin-6 production and accessory function in vitroJ. Neuroendocrinol. 943–53 (1997).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schwarz, M., Offenbaecher, M., Neumeister, A., Ackenheil, M. (2003). Experimental Evaluation of an Altered Tryptophan Metabolism in Fibromyalgia. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0135-0_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4939-6

  • Online ISBN: 978-1-4615-0135-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics